PDE5 Inhibitor Treatment Persistence and Adherence in Brazilian Men: Post-hoc Analyses from a 6-Month, Prospective, Observational Study

Chen KK, 2004, Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study, J Sex Med, 1, 201, 10.1111/j.1743-6109.2004.04029.x

Rodríguez Vela L, 2006, Tadalafil vs sildenafil patient preference in Spanish men with erectile dysfunction: results from an International Multicentric Study, Actas Urol Esp, 30, 67

Moreira ED, 2001, Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior, Urology, 58, 583, 10.1016/S0090-4295(01)01274-2

Sadovsky R, 2011, Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health, J Am Acad Nurse Pract, 23, 320, 10.1111/j.1745-7599.2010.00590.x

Sato Y, 2007, How long do patients with erectile dysfunction continue to use sildenafil citrate? Dropout rate from treatment course as outcome in real life, Int J Urol, 14, 339, 10.1111/j.1442-2042.2007.01608.x

Fisher WA, 2005, Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil, J Sex Med, 2, 699, 10.1111/j.1743-6109.2005.00119.x

Rosen R, 2007, The Treatment Satisfaction Scale (TSS) is a sensitive measure of treatment effectiveness for both patients and partners: results of a randomized controlled trial with vardenafil, J Sex Med, 4, 1009, 10.1111/j.1743-6109.2007.00527.x

Seftel AD, 2009, Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily, Int J Impot Res, 21, 240, 10.1038/ijir.2009.22

Mulhall JP, 2005, Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction, J Sex Med, 2, 848, 10.1111/j.1743-6109.2005.00149.x

Roumeguère T, 2008, Therapeutic response after first month of tadalafil treatment predicts 12 months treatment continuation in patients with erectile dysfunction: results from the DETECT study, J Sex Med, 5, 1708, 10.1111/j.1743-6109.2008.00790.x

Jiann BP, 2006, Compliance of sildenafil treatment for erectile dysfunction and factors affecting it, Int J Impot Res, 18, 146, 10.1038/sj.ijir.3901379

Klotz T, 2005, Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)?, Int J Impot Res, 17, 2, 10.1038/sj.ijir.3901252

Rubio-Aurioles E, 2013, A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction, Curr Med Res Opin, 29, 695, 10.1185/03007995.2013.791262

Rosen RC, 1997, The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0

Althof SE, 1999, EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction, Urology, 53, 793, 10.1016/S0090-4295(98)00582-2

Cappelleri JC, 2004, Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction, Int J Impot Res, 16, 30, 10.1038/sj.ijir.3901095

Gonzalgo ML, 2003, Clinical efficacy of sildenafil citrate and predictors of long-term response, J Urol, 170, 503, 10.1097/01.ju.0000071478.69480.fd

Souverein PC, 2002, Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users, Int J Impot Res, 14, 259, 10.1038/sj.ijir.3900883